mAb 8B4 |
37–44 |
Santa Cruz Biotechnology, Santa Cruz, CA, USA |
mAb 5G5 |
73–85 |
(25) |
mAb 12B2 |
89 −93 |
CIDC, Lelystad, the Netherlands (14) |
mAb 1E4 |
97–108 |
Sanquin BV, Amsterdam, the Netherlands (14) |
mAb 3F4 |
109–112 |
Abcam, Cambridge, UK |
mAb F89-160-1-5 |
142–152 |
Calbiochem/Merck4Biosciences, Darmstadt, Germany |
mAb 1C5 |
119–130 |
(26) |
mAb 6H4 |
144–152 |
Prionics AG, Schlieren, Switzerland |
mAb 12F10 |
142–152 |
SPI-Bio/IBL Int., Hamburg, Germany |
C-20 antiserum |
220–231 |
Santa Cruz Biotechnology, Santa Cruz, CA, USA |
mAb BAR 236
|
213– 251
|
SPI-Bio/IBL Int., Hamburg, Germany
|
*mAb, monoclonal antibody; PrP, prion protein. |